Prevalence of diabetes and pre-diabetes in Sri Lanka: a new global hotspot-estimates from the Sri Lanka Health and Ageing Survey 2018/2019.
diabetes mellitus, type 2
epidemiology
longitudinal studies
Journal
BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
01
10
2022
accepted:
18
01
2023
entrez:
16
2
2023
pubmed:
17
2
2023
medline:
22
2
2023
Statut:
ppublish
Résumé
This study's objective was to produce robust, comparable estimates of the prevalence of diabetes and pre-diabetes in the Sri Lankan adult population, where previous studies suggest the highest prevalence in South Asia. We used data on 6661 adults from the nationally representative 2018/2019 first wave of the Sri Lanka Health and Ageing Study (SLHAS). We classified glycemic status based on previous diabetes diagnosis, and either fasting plasma glucose (FPG), or FPG and 2-hour plasma glucose (2-h PG). We estimated crude and age-standardized prevalence of pre-diabetes and diabetes and by major individual characteristics weighting the data to account for study design and subject participation. Crude prevalence of diabetes in adults was 23.0% (95% CI 21.2% to 24.7%) using both 2-h PG and FPG, and age-standardized prevalence was 21.8% (95% CI 20.1% to 23.5%). Using only FPG, prevalence was 18.5% (95% CI 7.1% to 19.8%). Previously diagnosed prevalence was 14.3% (95% CI 13.1% to 15.5%) of all adults. The prevalence of pre-diabetes was 30.5% (95% CI 28.2% to 32.7%). Diabetes prevalence increased with age until ages ≥70 years and was more prevalent in female, urban, more affluent, and Muslim adults. Diabetes and pre-diabetes prevalence increased with body mass index (BMI) but was as high as 21% and 29%, respectively, in those of normal weight. Study limitations included using only a single visit to assess diabetes, relying on self-reported fasting times, and unavailability of glycated hemoglobin for most participants. Our results indicate that Sri Lanka has a very high diabetes prevalence, significantly higher than previous estimates of 8%-15% and higher than current global estimates for any other Asian country. Our results have implications for other populations of South Asian origin, and the high prevalence of diabetes and dysglycemia at normal body weight indicates the need for further research to understand the underlying drivers.
Identifiants
pubmed: 36796852
pii: 11/1/e003160
doi: 10.1136/bmjdrc-2022-003160
pmc: PMC9936281
pii:
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Investigateurs
Vajira Dissanayake
(V)
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Lancet Diabetes Endocrinol. 2017 Mar;5(3):162
pubmed: 28235490
Diabet Med. 2008 Sep;25(9):1062-9
pubmed: 19183311
Ceylon Med J. 2019 Sep 30;64(3):103-110
pubmed: 32120460
Int J Equity Health. 2012 Dec 13;11:76
pubmed: 23237051
Demography. 2001 Feb;38(1):115-32
pubmed: 11227840
Diabetes Care. 2019 Mar;42(3):476-485
pubmed: 30659076
Eur J Health Econ. 2020 Jun;21(4):573-605
pubmed: 31989388
Int J Equity Health. 2018 Apr 17;17(1):45
pubmed: 29665834
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
Ceylon Med J. 2015 Sep;60(3):107-10
pubmed: 26520866
Int J Epidemiol. 2013 Aug;42(4):992-1001
pubmed: 23778574
Diabet Med. 2013 Mar;30(3):326-32
pubmed: 22998091
Vital Health Stat 2. 2020 Dec;(185):1-36
pubmed: 33541513
Lancet Diabetes Endocrinol. 2018 Dec;6(12):966-978
pubmed: 30287102
Diabetes Care. 2009 Feb;32(2):287-94
pubmed: 19017771
Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38
pubmed: 34964875
Diabetes Care. 1997 Dec;20(12):1859-62
pubmed: 9405907
Glob Heart. 2022 Aug 01;17(1):50
pubmed: 36051322
Diabetol Metab Syndr. 2012 May 31;4(1):24
pubmed: 22650800
Diabetes Care. 2016 Mar;39(3):472-85
pubmed: 26908931